Dyslipidemia in youth: Epidemiology, pathophysiology, screening, management, and treatment: A review of the literature
Atherosclerotic cardiovascular disease (ASCVD) is one of the major causes of death all over the world. Atherosclerosis is developed by atherogenic lipoproteins and inflammation. Thus, dyslipidemia (DLP) is a major risk factor for developing ASCVD. DLP is a condition characterised by unnaturally high...
Main Authors: | Shahla V Esfarjani, Mehrnoosh Zakerkish |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=12;spage=7519;epage=7526;aulast=Esfarjani |
Similar Items
-
Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
by: Justine Cole, et al.
Published: (2023-09-01) -
Screening and Management of Dyslipidemia in Children and Adolescents
by: Juliette M. Schefelker, et al.
Published: (2022-10-01) -
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models
by: Samuel J Apple, et al.
Published: (2023-12-01) -
Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.
by: Francis Agyekum, et al.
Published: (2024-06-01) -
Managing dyslipidemia in solid organ transplant patients
by: Ashwani Mehta
Published: (2024-03-01)